Your Gut on a GLP-1: Side Effects, Root Causes, and Keeping the Weight Off

Written and Medically Reviewed by Dr. Dan Wool, NMD
Arizona-Licensed Naturopathic Physician and Gastroenterology Specialist
Updated: November 17, 2026
Quick Summary
GLP-1 medications such as semaglutide and tirzepatide work partly by slowing how fast your stomach empties. That slowing creates the fullness that drives weight loss. It also drives most of the nausea, reflux, bloating, and constipation people feel on these drugs.
Digestive side effects are common, and serious complications are uncommon. Pancreatitis, bowel obstruction, gastroparesis, and gallbladder disease all show up more often in GLP-1 users. Severe abdominal pain, vomiting you can't stop, or fever deserves an urgent call to your prescriber.
How your gut handles a GLP-1 depends on factors you can influence. Dose escalation speed, meal size, fluid and fiber, an already sluggish gut, protein intake, and strength training all shape how treatment goes and how much muscle you keep.
I use GLP-1 medications inside a root-cause plan. That means testing the gut and body composition first, climbing the dose slowly, protecting muscle, and planning for the day the medication stops. Most people regain much of their weight when treatment ends without that plan.
Marisol (not her real name) is 48 and runs the front office of a busy dental practice in Chandler.
Four months into weekly semaglutide, she had lost 31 pounds, and her prescriber was thrilled. She was miserable.
She went five days at a time without a bowel movement, felt queasy most afternoons, and found more hair in the shower drain than she had ever seen.
Nobody had asked what she was eating. The honest answer was one small meal a day plus coffee, because she was never hungry.
Her strength at the gym had dropped along with the scale. Her labs were normal and her weight kept falling. By every measure anyone was tracking, the medication was working.
I've heard some version of Marisol's story frequently in my Scottsdale practice.
GLP-1 medications are among the most effective tools medicine has produced for weight and blood sugar. They also work directly through the gut. But, when the gut isn't ready, the side effects can erase a lot of the benefit.
This guide covers what these drugs do to your digestion, why some people struggle on them, and how I use them inside a root-cause plan.
What GLP-1 Therapy Means for Your Gut
GLP-1 stands for glucagon-like peptide-1. Your own intestine makes this hormone after every meal.
Specialized cells in the lower small intestine and colon release it. It signals your pancreas to release insulin, tells your brain you've had enough, and slows the rate your stomach empties. The medications copy that hormone at higher and far longer-lasting levels than your body produces on its own.
The class now has several members:
Semaglutide (Brands: Ozempic, Wegovy, Rybelsus)
Semaglutide acts on the GLP-1 receptor alone. In the STEP 1 trial, adults without diabetes lost an average of 14.9% of their body weight over 68 weeks on the weight-loss dose, compared with 2.4% on placebo.[1]
Tirzepatide (Brands: Mounjaro, Zepbound)
Tirzepatide adds a second gut hormone target called GIP. At the highest dose in the SURMOUNT-1 trial, average weight loss reached 20.9% at 72 weeks.[2]
Retatrutide (in trial)
Retatrutide adds a third target, the glucagon receptor.
In the phase 3 TRIUMPH-1 trial, published in October 2026, adults without diabetes on the top dose lost an average of 25.0% of their body weight at 80 weeks, compared with 3.9% on placebo.[3] The trial also reported more dysesthesia, an abnormal tingling or burning feeling in the skin, than older drugs in the class have shown. Lilly plans to file with the FDA in early 2027, so retatrutide is still investigational and not approved.
Oral options
A daily semaglutide pill and a small-molecule pill called orforglipron (Foundayo) were both approved for weight management within the past year. They work on the same receptor and carry the same gut considerations.
The gut effect that matters most is slower stomach emptying. In a controlled trial of liraglutide, an earlier drug in the class, people whose stomachs slowed the most also lost the most weight.[4] That slowing explains the fullness. It also explains most of the nausea, reflux, bloating, and constipation side effects.
Where GLP-1s Fit in Root-Cause Care
Some patients come in expecting me to talk them out of these medications. I won't.
Arizona licensure gives me full prescribing authority as a naturopathic physician, and for the right patient a GLP-1 is a sound clinical choice.
Excess body fat drives insulin resistance, fatty liver, sleep apnea, joint damage, and hormone disruption. A drug that meaningfully reduces it deserves respect.
The naturopathic therapeutic order still applies. Diet and lifestyle come first. Medication comes in when the foundation alone falls short or the cost of waiting is too high.
What changes in my practice is the work around the prescription. Before the first dose, I want to know how your gut moves, what you eat and how much muscle you carry.
We also plan for what happens the day the medication stops.
A GLP-1 started on a struggling gut tends to amplify the struggle.
How GLP-1 Side Effects Show Up
Digestive side effects are common with GLP-1s.
In the STEP 1 study, 74.2% of people on semaglutide reported a gastrointestinal side effect, compared with 47.9% on placebo.[1] Most were mild to moderate, and most clustered in the weeks when the dose was climbing.
In the gut, I see nausea that spikes after large or fatty meals, constipation that can stretch to several days, early diarrhea, burping and reflux, a heavy feeling high in the stomach, and bloating that builds through the afternoon.
Outside the gut, I see fatigue when food intake drops too low, dizziness from poor hydration, loss of strength, and hair shedding a few months into rapid weight loss.
Serious complications are uncommon, and they still matter. A 2023 analysis of health records found that people taking GLP-1 drugs for weight loss had higher rates of pancreatitis, bowel obstruction, and gastroparesis than people on an older weight-loss medication.[5] A meta-analysis of 76 randomized trials found a 37% higher relative risk of gallbladder and bile duct disease, and the risk rose with higher doses and longer use.[6]
Warning Signs That Need a Conventional Workup First
Some symptoms need a gastroenterologist or an emergency department before anything else:
Blood in your stool, or black, tarry stools.
Unintended weight loss beyond what your medication explains.
Iron deficiency anemia.
Symptoms that wake you from sleep.
Fever with diarrhea.
Trouble swallowing or persistent vomiting.
A family history of colon cancer, IBD, or celiac disease.
New bowel changes after age 50.
On a GLP-1, add four more:
Severe, steady upper abdominal pain that bores through to your back.
Pain under your right ribs with fever, or yellowing of your skin or eyes.
Vomiting that keeps you from holding down fluids.
No stool or gas with a swollen, painful belly.
Conventional medicine handles this part well, and these symptoms belong there first.
What a Normal Scope and Normal Labs Don't Measure
A standard panel checks glucose, HbA1c, liver enzymes, and kidney function.
A scope can rule out ulcers, tumors, and visible inflammation.
Neither one tells you how fast your stomach empties, whether bacteria have overgrown in your small intestine, how well your microbiome supports your own GLP-1 production, or how much of your lost weight came from muscle.
A bathroom scale can't tell fat from muscle either. That gap is where most of my GLP-1 work happens.
How I Test Before and During GLP-1 Therapy
Body composition. I measure fat mass and lean mass at baseline and recheck every few months. Bioimpedance is convenient but shifts with hydration. DEXA is more precise but less accessible.
Metabolic labs. Fasting insulin, A1c, lipids, liver enzymes, and a full thyroid panel show where you're starting. Fasting insulin varies day to day, so I read trends.
Comprehensive stool testing. When bloating, constipation, or loose stools predate the medication, a stool panel helps map dysbiosis and inflammation. It is a snapshot of the colon and says little about the small intestine.
SIBO breath testing. For bloating with slow motility, a breath test can identify overgrowth. Slowed transit on a GLP-1 can complicate the timing, so I prefer to test before starting when I can.
Hormones and nutrients. Testosterone, SHBG, estradiol, ferritin, B12, and vitamin D round out the picture. No test predicts who will get nauseated, so the first few weeks always involve close follow-up.
7 Factors That Decide How Your Gut Handles a GLP-1
The count here follows the evidence and my clinical experience.
Climbing the dose too fast. Expert guidance on GI side effects centers on gradual escalation and holding at a tolerable dose longer when symptoms flare.[7] In my practice, I treat the published escalation schedule as the fastest allowed pace. The semaglutide and tirzepatide articles cover each drug's dosing steps.
Eating as if your stomach still empties on schedule. With emptying slowed, a large or high-fat meal can sit for hours.[4] Smaller meals, eating slowly, stopping at the first sign of fullness, and limiting greasy food are standard recommendations.[7] My fried foods and seed oils article explains why fat loads hit harder.
Too little fluid and fiber. Appetite drops, and drinking often drops with it. Hydration and fiber are first-line strategies for constipation on these drugs.[7] For patients with this presentation, I often recommend magnesium citrate or partially hydrolyzed guar gum (PHGG), which are worth discussing with your practitioner. See the fiber guide and the hydration myths article for more details.
An already slow or SIBO/SIFO gut. In my practice, patients who start with constipation, IBS-C, or SIBO have a harder time. These drugs slow transit further,[4] and a sluggish migrating motor complex gives bacteria more room to overgrow. The migrating motor complex article and SIBO guide cover that mechanism.
Rapid weight loss and the gallbladder. Gallbladder and bile duct disease rise with GLP-1 use, especially at weight-loss doses and with longer treatment.[6] Pain under the right ribs after meals deserves a call. The cholestasis article covers bile flow problems.
Losing muscle along with fat. Reviews of body composition data show that lean mass often accounts for a quarter or more of the weight lost on GLP-1 therapy.[8] Adequate protein and resistance training are the best-supported ways to protect it.[8] Muscle drives metabolic rate, blood sugar control, and strength as you age.
I see this mostly after people stop GLP-1s: People lose a lot of muscle mass during their prescription and then then, when they're done, what do we need going forward to burn fat? Muscle mass. And we are stuck with less than when we started therapy; without a strategy ahead of time, this makes rebound weight gain more likely and keeping weight off more difficult.Stopping without a plan. In the STEP 1 extension, people who stopped semaglutide regained about two-thirds of their lost weight within a year, and most of their metabolic improvements faded too.[9] The medication controls appetite while you take it. What you build during treatment determines what remains afterward.
The Hormone Connection
GLP-1 is a gut hormone first. Your intestinal cells release it in response to food, and your microbiome helps decide how much.
Short-chain fatty acids, which gut bacteria produce when they ferment fiber, stimulate GLP-1 release through a receptor called FFAR2 in laboratory studies.[10] A well-fed microbiome is part of how your body makes its own version of this drug.
Weight also moves sex hormones. In men, a meta-analysis found that weight loss raised testosterone, and greater loss produced larger gains.[11] In women, gut bacteria help regulate estrogen recycling through the estrobolome. Our master gut health guide walks through that mechanism, and it's the reason I check hormones alongside the gut when someone starts a GLP-1.
The Trouble With Calling Berberine 'Nature's Ozempic'
As a naturopathic doctor who regularly recommends botanicals, I want address something I frequently see and hear out there. Social media and supplement marketing have crowned berberine "nature's Ozempic."
The comparison falls apart on the data. In rat and cell studies, berberine increased GLP-1 release.[12] A meta-analysis of trials using berberine alone found improvements in lipids, insulin resistance, and some obesity measures.[13] Those effects are real and modest. Weight changes in berberine trials come nowhere near the 15% to 21% average losses reported for semaglutide and tirzepatide.[1][2]
In my practice, I often recommend berberine for blood sugar support and as part of SIBO and metabolic syndrome protocols for patients with those presentations. I don't sell it as a drug substitute. Patients who buy that promise often blame themselves when the scale barely moves.
How I Build a GLP-1 Plan That Outlasts the Prescription
Step 1: Rule out and screen. I clear the warning signs above and review contraindications. These include a personal or family history of medullary thyroid cancer or MEN2, prior pancreatitis, known gastroparesis, gallbladder history, and pregnancy plans.
Step 2: Test the baseline. Body composition, metabolic labs, hormones, and nutrient markers come first. Stool or breath testing follows when gut symptoms predate the medication.
Step 3: Steady the gut foundation. Constipation, overgrowth, and low fiber get addressed before the first dose whenever timing allows. Hydration, meal rhythm, and daily protein get set up in this phase.
Step 4: Start low and climb slowly. When a GLP-1 makes sense, we choose the medication together, start at the lowest dose, and move up only when symptoms allow. For nausea, I often recommend ginger for patients with this presentation. Strength training starts here too.
Step 5: Rebuild for life after the medication. We recheck body composition, keep training, support the microbiome, and decide together on a maintenance dose or a gradual taper based on your results.
Timeline: The foundation phase usually runs 4-8 weeks. Escalation in the STEP 1 trial took 16 weeks,[9] and I often take longer. I reassess every three months. Decisions about maintenance or tapering usually come after that.
GLP-1, Weight and Metabolic Health Hub Directory
Every article in this hub, grouped by what you're trying to figure out.
How GLP-1 drugs change digestion
GLP-1 medications and gut health: https://drdanwool.com/blog/glp1andguthealth
Comparing the medications
Semaglutide (Ozempic and Wegovy): https://drdanwool.com/blog/semaglutide
Tirzepatide (Mounjaro and Zepbound): https://drdanwool.com/blog/tirzepatide
Retatrutide and the triple-agonist trials: https://drdanwool.com/blog/retatrutide
The Bottom Line on GLP-1 Therapy and Your Gut
GLP-1 medications can change a person's metabolic future, and they run straight through the digestive tract. The side effects follow predictable patterns: dose speed, meal size, hydration, an already slow gut, the gallbladder, lost muscle, and an unplanned stop. Each one can be planned for.
For Marisol, the fix was unglamorous. We slowed her dose, rebuilt her protein and fluids, treated her constipation, and got her back in the gym. Six months later her bowels were regular, her hair had stopped shedding, and she was still losing weight with more of her muscle intact.
Related Reading
Gut Health: What It Is and How It Breaks Down: https://drdanwool.com/blog/gut-health-what-it-is-and-how-it-breaks-down
The IBS hub guide: https://drdanwool.com/blog/what-is-ibs-why-standard-treatment-fails
The dysbiosis hub guide: https://drdanwool.com/blog/gut-dysbiosis-what-it-means-how-to-test
The leaky gut hub guide: https://drdanwool.com/blog/leaky-gut-causes-testing-repair
The GERD and acid reflux hub guide: https://drdanwool.com/blog/gerd-acid-reflux-guide
The migrating motor complex: https://drdanwool.com/blog/migrating-motor-complex-mmc
Frequently Asked Questions about GLP-1 Medications and Gut Health
Why does Ozempic make me so constipated?
Quick Answer: Semaglutide slows how fast food moves through your gut, and most people eat and drink less on it.
Full Answer: Slower transit plus less fluid and fiber is a reliable recipe for constipation. It tends to be worst during dose increases. Hydration, fiber, and smaller frequent meals are first-line steps. In my practice I often add magnesium for patients with this presentation, which is worth discussing with your practitioner. No bowel movement with a swollen, painful belly needs urgent care.
Can GLP-1 medications cause gastroparesis?
Quick Answer: They slow stomach emptying by design, and a 2023 records study linked them to more gastroparesis diagnoses than an older weight-loss drug.
Full Answer: Mild slowing is how these drugs create fullness. Severe, lasting slowing is uncommon. Persistent vomiting, early fullness after a few bites, or food sitting for many hours should be reported to your prescriber right away.
Will I gain the weight back if I stop my GLP-1?
Quick Answer: Most people regain a large share if they stop without a plan.
Full Answer: In the STEP 1 extension, people regained about two-thirds of their lost weight within a year of stopping semaglutide. Protecting muscle, building eating habits during treatment, and tapering gradually are how I try to change that outcome.
How do I avoid losing muscle on a GLP-1?
Quick Answer: Eat enough protein and lift weights throughout treatment.
Full Answer: Lean mass often makes up a quarter or more of the weight lost on these drugs. Resistance training two to three times a week and protein at every meal are the best-supported protections. Body composition testing shows whether it's working, since the scale can't.
Is berberine a natural Ozempic?
Quick Answer: No. Berberine has modest metabolic benefits, and its weight effects are far smaller than those of GLP-1 drugs.
Full Answer: Berberine raised GLP-1 release in animal studies and improves lipids and insulin resistance in human trials. It can be a useful tool for blood sugar and gut support. Results were modest. Treating it as a drug replacement usually leads to disappointment.
Do GLP-1 medications cause gallstones?
Quick Answer: They raise the risk of gallbladder and bile duct disease, especially at weight-loss doses.
Full Answer: A meta-analysis of 76 trials found a 37% higher relative risk overall, with higher risk at larger doses and longer use. Pain under the right ribs after meals, fever, or yellowing skin should be checked promptly.
Can a naturopathic doctor prescribe semaglutide or tirzepatide in Arizona?
Quick Answer: Yes. Arizona-licensed naturopathic physicians have prescribing authority that includes GLP-1 medications.
Full Answer: I prescribe these drugs when they fit a patient's goals and health picture. Every prescription in my practice comes with gut and body composition testing, a slow dosing plan, and a strategy for maintenance or tapering.
Build a GLP-1 Plan Your Gut Can Handle
Dr. Wool's Gut Repair Plan starts with extended visits, specialty testing conventional workups rarely include, and a treatment plan built around root cause rather than symptom management.
See if we're a fit → Book a 15-minute call with Dr. Wool. No cost, no obligation. https://www.drdanwool.com/booking
References
1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
3. Jastreboff AM, Kaplan LM, Davies MJ, et al. Retatrutide, a triple hormone receptor agonist, for treatment of obesity. N Engl J Med. Published online September 29, 2026. doi:10.1056/NEJMoa2604169. https://doi.org/10.1056/NEJMoa2604169
4. Halawi H, Khemani D, Eckert D, et al. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial. Lancet Gastroenterol Hepatol. 2017;2(12):890-899. https://pubmed.ncbi.nlm.nih.gov/28958851/
5. Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M. Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss. JAMA. 2023;330(18):1795-1797. https://pubmed.ncbi.nlm.nih.gov/37796527/
6. He L, Wang J, Ping F, et al. Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2022;182(5):513-519. https://pubmed.ncbi.nlm.nih.gov/35344001/
7. Wharton S, Davies M, Dicker D, et al. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad Med. 2022;134(1):14-19. https://pubmed.ncbi.nlm.nih.gov/34775881/
8. Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26(suppl 4):16-27. https://pubmed.ncbi.nlm.nih.gov/38937282/
9. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. https://pubmed.ncbi.nlm.nih.gov/35441470/
10. Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61(2):364-371. https://pubmed.ncbi.nlm.nih.gov/22190648/
11. Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168(6):829-843. https://pubmed.ncbi.nlm.nih.gov/23482592/
12. Yu Y, Liu L, Wang X, et al. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochem Pharmacol. 2010;79(7):1000-1006. https://pubmed.ncbi.nlm.nih.gov/19945441/
13. Ye Y, Liu X, Wu N, et al. Efficacy and safety of berberine alone for several metabolic disorders: a systematic review and meta-analysis of randomized clinical trials. Front Pharmacol. 2021;12:653887. https://pubmed.ncbi.nlm.nih.gov/33981233/
Disclaimer
The information provided on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Dr. Dan Wool nor his affiliates do not make claims about the effectiveness of supplements, peptides, hormones or other therapies outside of the contexts supported by cited clinical evidence and regulatory approval. Always consult a qualified healthcare provider before starting, changing, or stopping any medical or wellness program.
Fix Your Gut, Solve Your Health
Dr. Wool's Gut Repair Plan starts with extended visits, specialty testing conventional workups rarely include, and a treatment plan built around root cause rather than symptom management. See if we're a fit → Book a 15-minute call with Dr. Wool. No cost, no obligation.
Get StartedDisclaimer: The information provided on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Dr. Dan Wool nor his affiliates do not make claims about the effectiveness of supplements, peptides, hormones or other therapies outside of the contexts supported by cited clinical evidence and regulatory approval. Always consult a qualified healthcare provider before starting, changing, or stopping any medical or wellness program.
Related Posts

A Naturopathic Guide to Crohn's Disease and Ulcerative Colitis
A naturopathic look at Crohn’s disease and ulcerative colitis: flare drivers, helpful testing, diet strategies, and co-managed care.

Why You're Bloated Every Day and What It's Telling You
Daily bloating usually has a pattern—and that pattern can reveal the cause. Learn the most common drivers, warning signs, and what to do next.

The Gut Supplements Worth Taking, Matched to Your Symptoms
Evidence-based gut supplement choices matched to common symptoms like IBS cramping, reflux, constipation, and antibiotic-related digestive upset.
